Finally, AIs are regularly negative also in AQP4-IgG-positive neuromyelitis optica spectrum disorders (NMOSD) [53] and in MOG-IgG-positive encephalomyelitis [54–58], two diseases in which a direct pathogenic impact of the antibody has been proven or is﻿ highly likely. The gene discussed is MOG; the disease is neuromyelitis optica.